Outset Medical OM
NASDAQ OM
$4.21 -0.09 (-2.09%)
At close: Aug 21, 2026 · 4:00 PM EDT

Outset Medical (OM) Invested Capital (2019 - 2022)

Outset Medical (OM) posted quarterly Invested Capital of $1.0 million for Q2 2022, down 86.67% quarter-over-quarter from $7.5 million in Q4 2019.

Outset Medical (OM) Invested Capital (2019 - 2022) Analysis & Trends

Outset Medical (OM) has reported Invested Capital for 2 consecutive years, with $1.0 million the latest figure, recorded in Q2 2022.

  • In Q2 2022, Invested Capital changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2023 stood at $1.0 million (changed N/A YoY), while the FY2019 annual figure was $7.5 million, changed N/A from the prior year.
  • Invested Capital retreated to $1.0 million in Q2 2022 per OM's latest filing, from $7.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $7.5 million in Q4 2019 and bottomed at $1.0 million in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 3.01 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 750.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 243.40 Mn
10 Outset Medical 78.20 Mn -184.99 Mn 13.28 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 1.00 Mn
Dec 31, 2019 7.50 Mn